Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers, Aged”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04476303
What this trial is testing

Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants

Who this might be right for
Alzheimer's Disease
BeyondBio Inc. 88
Early research (Phase 1)Study completedNCT05987488
What this trial is testing

ShigETEC Vaccine Study in Bangladesh

Who this might be right for
Healthy Volunteers
Eveliqure Biotechnologies GmbH 196
Not applicableStudy completedNCT05184387
What this trial is testing

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.

Who this might be right for
Influenza
Osivax 66
Very early researchStudy completedNCT02844621
What this trial is testing

Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults

Who this might be right for
Healthy Volunteers
The University of Texas Health Science Center at San Antonio 25
Large-scale testing (Phase 3)Study completedNCT02147548
What this trial is testing

Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly

Who this might be right for
Healthy Volunteers
Biocodex 31
Early research (Phase 1)Study completedNCT04169906
What this trial is testing

A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)

Who this might be right for
Healthy Volunteer
Taisho Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT04824638
What this trial is testing

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

Who this might be right for
HealthyImmunization; Infection
ANRS, Emerging Infectious Diseases 267
Early research (Phase 1)Study completedNCT01953848
What this trial is testing

Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)

Who this might be right for
EC905PharmacokineticsMultiple Dose+1 more
Astellas Pharma Europe B.V. 27
Not applicableLooking for participantsNCT06620185
What this trial is testing

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Who this might be right for
Influenza
Imperial College London 36
Testing effectiveness (Phase 2)Study completedNCT00454909
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 873
Not applicableStudy completedNCT00026598
What this trial is testing

Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 90
Testing effectiveness (Phase 2)Study completedNCT02640404
What this trial is testing

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 224
Testing effectiveness (Phase 2)Study completedNCT00161772
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Large-scale testing (Phase 3)Study completedNCT06049927
What this trial is testing

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 3,300
Early research (Phase 1)Study completedNCT02161796
What this trial is testing

Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects

Who this might be right for
PK for FG-4592Healthy Subjects
Astellas Pharma Europe B.V. 48
Early research (Phase 1)Study completedNCT06554574
What this trial is testing

Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants

Who this might be right for
Healthy
Latigo Biotherapeutics 112
Large-scale testing (Phase 3)Study completedNCT03890367
What this trial is testing

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 707
Early research (Phase 1)Study completedNCT01477619
What this trial is testing

Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects

Who this might be right for
Healthy Volunteers
Vanda Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT05995275
What this trial is testing

Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

Who this might be right for
SmallpoxMpox
ModernaTX, Inc. 351
Testing effectiveness (Phase 2)UnknownNCT05409300
What this trial is testing

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Who this might be right for
COVID-19Vaccine Adverse ReactionSars-CoV-2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Next Page